However, it is essential to approach this topic carefully, separating ongoing research from unsupported claims
(The agency has not announced that it intends to do so.) "Ultimately, what we would hope is, before the end of the year, patients would be able to go to their doctor, work through maybe a telehealth provider, and then be able to get a prescription for this under monitored medical supervision," he said
Participants in the liraglutide group demonstrated a similar pattern, with mean weight loss decreasing from 8.5% at week 26 to 7.2% at week 32, indicating partial weight gain after discontinuation [1]
Therapeutic management Recommendations and suggestions R2.7 We recommend that DSD counseling/therapy should be an interdisciplinary task, performed in centers of excellence aiming to achieve the best quality of life and acceptance of individual anatomy
In the REDEFINE 1 phase 3 trial, cagrilintide 2.4 mg monotherapy produced an average body weight reduction of 11.8% over 68 weeks